Long-term maraviroc use as salvage therapy in HIV-2 infection.
Umbelina
U
Caixas
Joana
J
Ferreira
Aline T
AT
Marinho
Inês
I
Faustino
Nádia M
NM
Grilo
Fátima
F
Lampreia
Isabel
I
Germano
Emília C
EC
Monteiro
Sofia A
SA
Pereira
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D018791:CD4 Lymphocyte Count; D003510:Cyclohexanes / Q000008:administration & dosage*; D016903:Drug Monitoring; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015498:HIV-2 / Q000302:isolation & purification*; D006801:Humans; D000077592:Maraviroc; D016879:Salvage Therapy / Q000379:methods*; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage*
D019380:Anti-HIV Agents; D003510:Cyclohexanes; D014230:Triazoles; D000077592:Maraviroc